LabCorp unveiled its latest solution for decentralized clinical trials from Covance to help transform the conduct of hybrid and virtual trials. This decentralized clinical trials offering is underpinned by highly diverse, global data that enables faster identification of potential candidates for a trial. The solution integrates Covance central laboratories, LabCorp specialty diagnostic laboratories, direct-to-patient market access call centers, and a suite of technology solutions to bring the trial closer to the patient, and streamline trial execution. The Covance decentralized trials offering is powered by a suite of integrated, modular, and highly configurable technology solutions that can be customized to deliver any conforming study protocol.